SEATTLE, June 05, 2024--Know Labs, Inc. (NYSE American: KNW), a leading developer of non-invasive medical diagnostic technology, today announced that it has joined the Industrial Participant Program of the Wyss Institute for Biologically Inspired Engineering at Harvard University’s Diagnostics Accelerator.
SEATTLE, May 16, 2024--Know Labs, Inc. (NYSE American: KNW), an emerging leader in non-invasive medical diagnostic technology, today announced the appointment of Chris Somogyi as President, International. With over 40 years of experience in commercializing innovation across related industries, Somogyi brings a wealth of expertise to lead the Company's "Skunkworks" Program and global patent licensing efforts.
Despite a reduced operating loss and advancements in noninvasive glucose monitoring technology, Know Labs faces ongoing financial and developmental hurdles.